Gisela Schwab - Jul 21, 2021 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role: Pres, Prod Dev & Med Aff & CMO
Signature: /s/ Jennifer Drimmer Rokovich, Attorney in Fact
Stock symbol: EXEL
Transactions as of: Jul 21, 2021
Transactions value $: $147,000
Form type: 4
Date filed: 7/23/2021, 07:47 PM
Previous filing: Jul 2, 2021
Next filing: Jul 28, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EXEL	Common Stock	Options Exercise	$147K	+35K	+5.7%	$4.20^*	649K	Jul 21, 2021	Direct	F1
holding	EXEL	Common Stock						14.9K	Jul 21, 2021	By 401(k)	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EXEL	Option (right to buy)	Options Exercise	$0	-35K	-46.67%	$0.00	40K	Jul 21, 2021	Common Stock	35K	$4.20	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
F2	Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of July 20, 2021.
F3	The option, representing the right to purchase a total of 75,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020.